Concepedia

Mike Dolph

MD

7

Publications

116

Citations

7

H-Index

2018

Active since

Affiliations

Novartis (United States)(Current)

Tris Pharma (United States)

University of Glasgow

Novartis (United Kingdom)

Mike Dolph is an author at Novartis (United States) specializing in medicine, hematology, and oncology.

Top concepts

Publications per year

2018–2020

7

Publications

7

Systematic review of health state utility values for acute myeloid leukemia

Anna Forsythe, Patricia Brandt, Mike Dolph et al. · ClinicoEconomics and Outcomes Research · 2018 · 31 citations · Full text

Matching-adjusted indirect treatment comparison of ribociclib and palbociclib in HR+, HER2− advanced breast cancer

Gabriel Tremblay, David Chandiwana, Mike Dolph et al. · Cancer Management and Research · 2018 · 25 citations · Full text

Cost-effectiveness analysis for midostaurin versus standard of care in acute myeloid leukemia in the United Kingdom

Gabriel Tremblay, Mike Dolph, Sachin Patel et al. · Cost Effectiveness and Resource Allocation · 2018 · 15 citations · Full text

The Cost-effectiveness of Eltrombopag for the Treatment of Immune Thrombocytopenia in the United States

Gabriel Tremblay, Mike Dolph, Anuja Roy et al. · Clinical Therapeutics · 2020 · 13 citations

, , +12

Cost-consequence model comparing eltrombopag and romiplostim in pediatric patients with chronic immune thrombocytopenia

Gabriel Tremblay, Mike Dolph, Menaka Bhor et al. · ClinicoEconomics and Outcomes Research · 2018 · 12 citations · Full text

Rows per page

1–5 of 7